Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.081,24
0,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gene Logic Inc. (MM) (GLGC) Gene Logic Inc. (MM) (GLGC) Notizie

GLGC

Gene Logic Inc. (MM) (GLGC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GLGC
DataOraFonteTitoloSimboloCompagnia
20/12/200723:18Edgar (US Regulatory)Gene Logic Inc - Current report filing (8-K)NASDAQ:GLGCGene Logic Inc. (MM)
18/12/200721:20Edgar (US Regulatory)Gene Logic Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:GLGCGene Logic Inc. (MM)
14/12/200723:00Business WireGene Logic Inc. Completes Sale of Genomics Assets to Ocimum BiosolutionsNASDAQ:GLGCGene Logic Inc. (MM)
11/12/200712:00Business WireGene Logic Shareholders Approve Genomics Assets Sale and Company Name Change to Ore PharmaceuticalsNASDAQ:GLGCGene Logic Inc. (MM)
09/11/200721:42Edgar (US Regulatory)Gene Logic Inc - Quarterly Report (10-Q)NASDAQ:GLGCGene Logic Inc. (MM)
05/11/200722:24Edgar (US Regulatory)Gene Logic Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:GLGCGene Logic Inc. (MM)
26/10/200722:55Edgar (US Regulatory)Gene Logic Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary)NASDAQ:GLGCGene Logic Inc. (MM)
25/10/200712:03Edgar (US Regulatory)Gene Logic Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:GLGCGene Logic Inc. (MM)
18/10/200723:26Edgar (US Regulatory)Gene Logic Inc - Amended Current report filing (8-K/A)NASDAQ:GLGCGene Logic Inc. (MM)
31/07/200719:00Business WireGene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical DevelopmentNASDAQ:GLGCGene Logic Inc. (MM)
27/07/200714:45Business WireGene Logic Drug Candidate Shows Positive In Vivo Test ResultsNASDAQ:GLGCGene Logic Inc. (MM)
27/07/200712:00Business WireGene Logic Reports Second Quarter 2007 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
23/07/200717:00Business WireGene Logic to Announce Second Quarter 2007 Financial Results on July 27, 2007NASDAQ:GLGCGene Logic Inc. (MM)
28/06/200712:00Business WireGene Logic Enters Into Agreement with Lundbeck to Discover New Development Paths for Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
18/06/200717:15Business WireGene Logic Collaboration Reveals Genomic Predictors of Parkinson's DiseaseNASDAQ:GLGCGene Logic Inc. (MM)
10/05/200720:10Business WireGene Logic and Abbott Enter Collaboration to Discover New Development Paths for Multiple Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
27/04/200712:00Business WireGene Logic Reports First Quarter 2007 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
20/04/200712:00Business WireGene Logic to Announce First Quarter 2007 Financial Results on April 27, 2007NASDAQ:GLGCGene Logic Inc. (MM)
16/04/200722:42Business WireGene Logic Promotes Dr. Thomas Barnes to Lead Drug Repositioning Discovery EffortsNASDAQ:GLGCGene Logic Inc. (MM)
11/04/200722:07Business WireGene Logic Board Elects Two New DirectorsNASDAQ:GLGCGene Logic Inc. (MM)
22/03/200711:00Business WireGene Logic Names New CEONASDAQ:GLGCGene Logic Inc. (MM)
09/11/200613:00Business WireGene Logic Reports Third Quarter 2006 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
07/11/200613:00Business WireGene Logic to Announce Third Quarter 2006 Financial Results on November 9, 2006NASDAQ:GLGCGene Logic Inc. (MM)
12/10/200613:00Business WireGene Logic Enters into Agreement with Lilly to Discover New Development Paths for Multiple Clinical Drug CandidatesNASDAQ:GLGCGene Logic Inc. (MM)
22/09/200613:00Business WireGene Logic Provides Update on Business ReviewNASDAQ:GLGCGene Logic Inc. (MM)
10/08/200613:00Business WireGene Logic Provides the FDA with Access to Toxicogenomics Data and Analysis Systems for Reviewing Voluntary Genomic Data SubmisNASDAQ:GLGCGene Logic Inc. (MM)
04/08/200613:00Business WireGene Logic Reports Second Quarter 2006 Financial ResultsNASDAQ:GLGCGene Logic Inc. (MM)
01/08/200622:15Business WireGene Logic Restructures Genomics DivisionNASDAQ:GLGCGene Logic Inc. (MM)
26/07/200613:00Business WireGene Logic to Announce Second Quarter 2006 Financial Results on August 4, 2006NASDAQ:GLGCGene Logic Inc. (MM)
22/06/200613:30Business WireGene Logic to Realize Lower-Than-Expected Revenue for Its Genomics Division; Financial Guidance WithdrawnNASDAQ:GLGCGene Logic Inc. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GLGC

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network